Skip to main content
Article thumbnail
Location of Repository

Synthesis and characterization of nanoscale dendritic RGD clusters for potential applications in tissue engineering and drug delivery

By Hu Yang and Weiyuan John Kao

Abstract

Spatial control over the distribution and the aggregation of arginine-glycine-aspartate (RGD) peptides at the nanoscale significantly affects cell responses. For example, nanoscale clustering of RGD peptides can induce integrins to cluster, thus triggering complete cell signaling. Dendrimers have a unique, highly branched, nearly spherical and symmetrical structure with low polydispersity, nanoscale size, and high functionality. Therefore, dendrimers are a class of ideal scaffold for construction of nanoscale dendritic RGD clusters in which RGD loading degree and cluster size can be finely adjusted. This new type of nanoscale dendritic RGD cluster will aid us to better understand the impact of spatial arrangement of RGD on cellular responses and to engineer RGD to trigger more favorable cellular responses. In this study, nanoscale dendritic RGD clusters were synthesized based on Starburst™ anionic G3.5 and cationic G4.0 polyamidoamine (PAMAM) dendrimers. The multiple terminal functional groups on the outermost layer of the dendrimer were coupled with RGD tripeptides. Biofunctionalized dendrimer structures were found to be highly dependent on the generation and the extent of peptide modification (ie, number of peptides per PAMAM dendrimer). Fluorescein isothiocyanate (FITC)-conjugated PAMAM dendrimers were utilized to monitor cellular internalization of dendrimers by adherent fibroblasts. Anionic G3.5-based dendritic RGD clusters have been shown to have no negative effect on fibroblast viability and a concentration-dependent effect on lowering cell adhesion on tissue culture polystyrene (TCPS) as that of free RGD. A similar concentration-dependent effect in cell viability and adhesion was also observed for cationic G4.0-based dendritic RGD clusters at lower but not at high concentrations. The results imply that the synthesized nanoscale dendritic RGD clusters have great potential for tissue engineering and drug delivery applications

Topics: Original Research
Publisher: Dove Medical Press
OAI identifier: oai:pubmedcentral.nih.gov:2673823
Provided by: PubMed Central

Suggested articles

Citations

  1. (1985). A new class of polymers: starburst-dendritic macromolecules.
  2. (1999). About dendrimers: structure, physical properties, and applications. Chem Rev (Washington DC),
  3. (1998). An RGD-oligolysine peptide: a prototype construct for integrin-mediated gene delivery. Human Gene Ther,
  4. (2000). Application of membrane-based dendrimer/DNA complexes for solid phase transfection in vitro and in vivo.
  5. (2000). Cell adhesion and motility depend on nanoscale RGD clustering.
  6. (1996). Dendrimer delivery of oligonucleotide. Drug Deliv,
  7. (2006). Dendrimers for pharmaceutical and biomedical applications.
  8. (2000). Dendrimers: Relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labeled polyamidoamine dendrimers in vivo.
  9. (1999). Evaluation of protein-modulated macrophage behavior on biomaterials: designing biomimetic materials for cellular engineering.
  10. (2005). Extended release of a novel antidepressant, venlafaxine, based on anionic polyamidoamine dendrimers and poly(ethylene glycol)-containing semi-interpenetrating networks.
  11. (1988). Focal adhesions: transmembrane junctions between the extracellular matrix and the cytoskeleton. Annu Rev Cell Biol,
  12. (2002). Imaging {Au0-PAMAM} Golddendrimer nanocomposites in cells.
  13. (2006). In vitro enzymatic stability of dendritic peptides.
  14. (1979). Initial adhesion of human fi broblasts in serumfree medium: possible role of secreted fi bronectin.
  15. (1995). Integrin function: molecular hierarchies of cytoskeletal and signaling molecules.
  16. (1998). Liposomes enhance delivery and expression of an RGD-oligolysine gene transfer vector in human tracheal cells. Gene Ther,
  17. (2001). Nanoscale clustering of RGD peptides at surfaces using Comb polymers. 1. Synthesis and characterization of Comb thin fi lms.
  18. (2001). Nanoscale clustering of RGD peptides at surfaces using comb polymers. 2. Surface segregation of comb polymers in polylactide.
  19. (1987). New perspectives in cell adhesion: RGD and integrins.
  20. (2001). Novel liver macromolecular MR contrast agent with a polypropylenimine diaminobutyl dendrimer core: Comparison to the vascular MR contrast agent with the polyamidoamine dendrimer core. Magn Reson Med,
  21. (2003). Penicillin V-conjugated PEG-PAMAM star polymers.
  22. (2002). Polyethylene glycol-conjugated PAMAM dendrimer for biocompatible, high-effi ciency DNA delivery.
  23. (2004). Polyethylene glycol-polyamidoamine dendritic micelle as solubility enhancer and the effect of the length of polyethylene glycol arms on the solubility of pyrene in water.
  24. (2001). Potential tumor-targeting peptide vector of histidylated oligolysine conjugated to a tumor-homing RGD motif. Cancer Gene Ther,
  25. (1996). Preliminary biological evaluation of polyamidoamine (PAMAM) starburst dendrimers.
  26. (2003). RGD modifi ed polymers: biomaterials for stimulated cell adhesion and beyond.
  27. (1991). Signal transduction by integrins: increased protein tyrosine phosphorylation caused by clustering of beta 1 integrins.
  28. (2002). Single-cell measurements of polyamidoamine dendrimer binding.
  29. (1995). Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function.
  30. (2005). Synthesis, cellular transport, and activity of polyamidoamine dendrimer-methylprednisolone conjugates. Bioconjug Chem,
  31. (1990). The activation dependent adhesion of macrophages to laminin involves cytoskeletal anchoring and phosphorylation of the alpha 6 beta 1 integrin.
  32. (2003). The infl uence of surface modifi cation on the cytotoxicity of PAMAM dendrimers.
  33. (2000). The use of PAMAM dendrimers in the effi cient transfer of genetic material into cells. Pharma Sci Technol Today,
  34. (2004). Transport of dendrimer nanocarriers through epithelial cells via the transcellular route.
  35. (2005). Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.